Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Malani, P. N.
Right arrow Articles by Zervos, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malani, P. N.
Right arrow Articles by Zervos, M. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2002) 49, 841-843
© 2002 The British Society for Antimicrobial Chemotherapy

Molecular analysis of vancomycin-resistant Enterococcus faecalis from Michigan hospitals during a 10 year period

Preeti N. Malani1,4, LeeAnn Thal1,2,5, Susan M. Donabedian1,2,5, Barbara Robinson-Dunn6,7, Carol A. Kauffman1,4, Joseph W. Chow1,2,6, Ellie Hershberger1,2,5 and Marcus J. Zervos1,2,5,6,*

1Departments of Internal Medicine; 2Division of Infectious Disease, 3Veterans Affairs Healthcare Center, Ann Arbor, MI; 4University of Michigan Medical School, Ann Arbor, MI; 5William Beaumont Hospital, Royal Oak, MI; 6Wayne State University, Detroit, MI; 7Michigan Department of Community Health, Lansing, MI, USA

Received 28 August 2001; returned 25 November 2001; revised 30 January 2002; accepted 5 February 2002.

We evaluated the molecular relatedness of 47 clinical isolates of vancomycin-resistant Enterococcus faecalis collected from 15 Michigan hospitals from 1991 to 2000. There were 17 PFGE strain types for the 47 isolates. Ten of 15 hospitals demonstrated interhospital, and three of 15 intrahospital, dissemination of some isolates. Forty-two isolates (89.4%) demonstrated vanB resistance. All vanA isolates comprised unique PFGE groups, suggesting transposon dissemination or the presence of a similar plasmid. The results of this study suggest inter- and intrahospital dissemination of strains of vancomycin-resistant E. faecalis during a 10 year period in Michigan.

* Correspondence address. William Beaumont Hospital, 3601 West 13 Mile Road, Royal Oak, MI 48073, USA. Tel: +1-248-551-0419; Fax: +1-248-551-5069; E-mail: mzervos{at}Beaumont.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
A. Singh, R. V. Goering, S. Simjee, S. L. Foley, and M. J. Zervos
Application of Molecular Techniques to the Study of Hospital Infection
Clin. Microbiol. Rev., July 1, 2006; 19(3): 512 - 530.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. F. Oprea, N. Zaidi, S. M. Donabedian, M. Balasubramaniam, E. Hershberger, and M. J. Zervos
Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis
J. Antimicrob. Chemother., April 1, 2004; 53(4): 626 - 630.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.